Results 41 to 50 of about 19,830 (241)

Rare primary peritoneal mucinous adenocarcinoma in a 69‐year‐old man

Clinical Case Reports, 2021
Primary peritoneal mucinous adenocarcinoma is rare in men. The low‐grade tumor consisted of mucin‐producing columnar cells with minimal nuclear atypia. Relationship to pseudomyxoma peritonei and disseminated peritoneal adenomucinosis is discussed.
Fumiko Satoh, Yutaka Tsutusmi
doaj   +1 more source

Pseudomyxoma Peritonei: A Case Report [PDF]

, 1970
Pseudomyxoma peritonei (PMP) is an uncommon condition characterized by abundant extracellular mucinous material in the peritoneal cavity and tumoural implants on the peritoneal and epiploic surfaces.
SM Kamal, MA Ahad, MA Bakar, M Yusuf Ali
core   +1 more source

Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy

Cancer Medicine, 2022
To establish a survival prognostic model for pseudomyxoma peritonei (PMP) treated with cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) based on Bayesian network (BN).
Xin Zhao, Xin-Bao Li, Yulin Lin, R. Ma, Ying Zhang, Dazhao Xu, Yan Li   +6 more
semanticscholar   +1 more source

New insights in the management of pseudomyxoma peritonei. [PDF]

J Surg Oncol
While a rare entity, peritoneal pseudomyxoma treatment evolves. Decision‐making criteria improve with imaging development and exploratory laparoscopy. Surgery remains at the core of the therapeutic strategy whatever disease progression.
Pastier C, De Hingh IHJT, Goéré D.
europepmc   +2 more sources

Cytoreductive Surgery and Hyperthermic Chemotherapy for Intrathoracic Pseudomyxoma Peritonei. [PDF]

, 2020
Dissemination of pseudomyxoma peritonei into the thoracic cavity is rare and carries a poor prognosis. Optimal treatment has not been defined. In our institution, patients had received cytoreductive surgery with hyperthermic intrathoracic chemotherapy ...
00452243, KAWAGUCHI, Yo, 7695, 0000-0002-5272-556X, 花岡, 淳, 0000-0002-7828-4635, HANAOKA, Jun, 川口, 庸, 173   +8 more
core   +2 more sources

Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR).

Digestive and Liver Disease, 2021
INTRODUCTION This document is a summary of the French Intergroup guidelines regarding the management of appendicular epithelial tumors (AT) and pseudomyxoma peritonei (PMP) published in March 2020, available on the website of the French Society of ...
J. Delhorme, L. Villeneuve, O. Bouché, G. Avérous, A. Dohan, J. Gornet, B. You, F. Bibeau, P. Dartigues, C. Eveno, J. Fontaine, V. Képénékian, M. Pocard, P. Rousset, F. Quénet, P. Mariani, O. Glehen, D. Goéré   +17 more
semanticscholar   +1 more source

A case of Pseudomyxoma Peritonei of an unexpected origin

Diagnostic Pathology, 2021
Background Pseudomyxoma peritonei (PMP) is a complex and partially understood disease defined by mucin deposits in the peritoneal cavity, mostly of appendiceal origin caused by the rupture of a mucocele often containing Low or High grade Appendiceal ...
Marie Csanyi-Bastien, France Blanchard, Aude Lamy, Jean-Christophe Sabourin   +3 more
doaj   +1 more source

Rapid recurrence of a ruptured mucinous borderline ovarian tumor harboring K-RAS mutation followed by progression into anaplastic carcinoma with TP53 mutation

Heliyon, 2022
We describe the case of a young patient with a borderline mucinous ovarian tumor that progressed into ipsilateral ovarian anaplastic carcinoma in only 3 months with metastasis to the contralateral ovary and extensive spread in the pelvic and abdominal ...
Yang Yang, Yanxian Guan, Manman Xu, Junxiu Liu   +3 more
doaj   +1 more source

First Report With Medium-term Follow-up of Intestinal Transplantation for Advanced and Recurrent Nonresectable Pseudomyxoma Peritonei

Annals of Surgery, 2022
Objective: To report our experience with the combination of radical surgical excision and intestinal transplantation in patients with recurrent pseudomyxoma peritonei (PMP) not amenable to further cytoreductive surgery (CRS).
S. Reddy, S. Punjala, P. Allan, A. Vaidya, D. Borle, Henk Geiele, V. Udupa, Alison Smith, L. Vokes, G. Vrakas, F. Mohamed, S. Dayal, B. Moran, P. Friend, T. Cecil   +14 more
semanticscholar   +1 more source

The management of pseudomyxoma peritonei [PDF]

Cancer, 1990
The management of nine patients with pseudomyxoma peritonei was reviewed. Aggressive surgical resection of tumor is the standard of treatment, with many patients requiring multiple laparotomies. Chemotherapy, including the use of cisplatin is not effective. Long-term nutritional support provides a better quality of survival for select patients.
W J, Mann, J, Wagner, J, Chumas, E, Chalas   +3 more
openaire   +2 more sources